Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VT4

EBOV GP/BA2-VHH complex

Summary for 9VT4
Entry DOI10.2210/pdb9vt4/pdb
EMDB information65314
DescriptorEnvelope glycoprotein,GP1, Envelope glycoprotein, nanobody BA2, ... (4 entities in total)
Functional Keywordsebolavirus, glycoprotein, nanobody, complex, membrane protein
Biological sourceZaire ebolavirus
More
Total number of polymer chains9
Total formula weight200624.55
Authors
Wang, M.,Gao, Y.,Jin, T. (deposition date: 2025-07-09, release date: 2026-07-08)
Primary citationWang, M.,Zhang, X.,Li, W.,Yao, Y.,Li, E.,Zhang, B.,Zhou, J.,Liu, S.,Gao, Y.,Zhu, Z.,Zhu, L.,Liu, M.,Hu, J.,Peng, C.,Li, F.,Chen, M.,Liu, H.,Yao, C.,Shang, Y.,Yan, F.,Gong, P.,Jin, T.,Chiu, S.
A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus.
Nat Commun, 17:-, 2026
Cited by
PubMed Abstract: The highly lethal Ebola virus species-Zaire (EBOV), Sudan (SUDV), and Bundibugyo (BDBV)-pose persistent threats to global health. Current antibody therapies target EBOV but lack broad neutralization across ebolaviruses. Recent pan-ebolavirus strategies rely on antibody cocktails. Here, we identified two camelid-derived nanobodies (1A10 and BA2) that neutralize EBOV, SUDV, and BDBV in vitro and protect female rodents against these pathogens. High-resolution cryo-EM structures of their GP complexes showed that 1A10 and BA2 bind conserved but non-overlapping epitopes near the GP1 base and GP2's internal fusion loop (IFL), and biochemical analyses revealed their distinct neutralization mechanisms. To further improve efficacy, we engineered a bispecific antibody (BA2-1A10) via GS linker-mediated IgG-Fc fusion, which provided highly potent protection against all three viruses in female rodents model and positions it as a strong broad-spectrum anti-ebolavirus candidate. Our work demonstrates a structure-guided bispecific nanobody strategy for pan-ebolavirus therapy and highlights compact antibodies for next-generation antivirals.
PubMed: 41839884
DOI: 10.1038/s41467-026-70464-6
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.96 Å)
Structure validation

256158

건을2026-07-08부터공개중

PDB statisticsPDBj update infoContact PDBjnumon